StockData
Prothena Corp Public Ltd Co logo

Prothena Corp Public Ltd Co (PRTA) stock

PRTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3024% below fair value
$8.26+0.29 (+3.64%)

Close on Nov 17, 2026Market cap $424.04MP/E –Yield –

Prothena Corp Public price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Prothena Corp Public's price to book ratio was 1.6× on Nov 11, 2026, against 2.0× a year earlier. Over the last 5 years it ranged from 0.6× to 7.4×, with a median of 2.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×−0.2
2025Dec 31, 20251.7×+0.3
2024Dec 31, 20241.4×−1.8
2023Dec 29, 20233.2×−4.0
2022Dec 30, 20227.1×+2.4
2021Dec 31, 20214.7×+2.4
2020Dec 31, 20202.3×+0.1
2019Dec 31, 20192.2×+1.0
2018Dec 31, 20181.2×−2.0
2017Dec 29, 20173.2×−1.0
2016Dec 30, 20164.2×−1.5
2015Dec 31, 20155.7×+3.8
2014Dec 31, 20141.9×−2.9
2013Dec 31, 20134.7×–

More Prothena Corp Public figures

See a number that looks wrong?